BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Okamoto T, Koda M, Miyoshi K, Onoyama T, Kishina M, Matono T, Sugihara T, Hosho K, Okano J, Isomoto H, Murawaki Y. Antifibrotic effects of ambrisentan, an endothelin-A receptor antagonist, in a non-alcoholic steatohepatitis mouse model. World J Hepatol 2016; 8(22): 933-941 [PMID: 27574547 DOI: 10.4254/wjh.v8.i22.933]
URL: https://www.wjgnet.com/1948-5182/full/v8/i22/933.htm
Number Citing Articles
Francesca Schinzari, Carmine Cardillo. Intricacies of the endothelin system in human obesity: role in the development of complications and potential as a therapeutic targetCanadian Journal of Physiology and Pharmacology 2020; 98(9): 563 doi: 10.1139/cjpp-2019-0651
Osvaldo Rivera-Gonzalez, Natalie A. Wilson, Laura E. Coats, Erin B. Taylor, Joshua S. Speed. Endothelin receptor antagonism improves glucose handling, dyslipidemia, and adipose tissue inflammation in obese miceClinical Science 2021; 135(14): 1773 doi: 10.1042/CS20210549
Guillermo A. Ortiz, Guadalupe Garcia-Tsao. Future Pharmacological Therapies of Portal HypertensionCurrent Hepatology Reports 2019; 18(1): 36 doi: 10.1007/s11901-019-00448-2
Stefania Cannito, Erica Novo, Maurizio Parola. Therapeutic pro-fibrogenic signaling pathways in fibroblastsAdvanced Drug Delivery Reviews 2017; 121: 57 doi: 10.1016/j.addr.2017.05.017
Henrik H. Hansen, Michael Feigh, Sanne S. Veidal, Kristoffer T. Rigbolt, Niels Vrang, Keld Fosgerau. Mouse models of nonalcoholic steatohepatitis in preclinical drug developmentDrug Discovery Today 2017; 22(11): 1707 doi: 10.1016/j.drudis.2017.06.007
Hongshan Li, Hao Ying, Airong Hu, Yaoren Hu, Dezhou Li. Therapeutic Effect of Gypenosides on Nonalcoholic Steatohepatitis <i>via</i> Regulating Hepatic Lipogenesis and Fatty Acid OxidationBiological & Pharmaceutical Bulletin 2017; 40(5): 650 doi: 10.1248/bpb.b16-00942
Jie Wang, Lili An, Yun Zhao, Cheng Zhang, Shengnan Li, Chen Ye, Shuqian Jing, Haiying Hang. In vitro affinity maturation of antibody against membrane-bound GPCR moleculesApplied Microbiology and Biotechnology 2019; 103(18): 7703 doi: 10.1007/s00253-019-10030-x
Li Feng, Songhua Wang, Feng Chen, Cheng Zhang, Qiao Wang, Yuting Zhao, Zifeng Zhang. Hepatic Knockdown of Endothelin Type A Receptor (ETAR) Ameliorates Hepatic Insulin Resistance and Hyperglycemia Through Suppressing p66Shc-Mediated Mitochondrial Fragmentation in High-Fat Diet-Fed MiceDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021; : 963 doi: 10.2147/DMSO.S299570
Calen A. Steiner, Peter D. R. Higgins. Fibrostenotic Inflammatory Bowel Disease2018; : 347 doi: 10.1007/978-3-319-90578-5_23